Twist Bioscience Corp (TWST)
43.34
+0.55
(+1.29%)
USD |
NASDAQ |
Oct 04, 16:00
43.41
+0.07
(+0.16%)
After-Hours: 20:00
Twist Bioscience SG&A Expense (TTM): 212.65M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 212.65M |
March 31, 2024 | 201.91M |
December 31, 2023 | 200.25M |
September 30, 2023 | 189.74M |
June 30, 2023 | 196.50M |
March 31, 2023 | 204.14M |
December 31, 2022 | 204.17M |
September 30, 2022 | 212.95M |
June 30, 2022 | 197.03M |
March 31, 2022 | 177.82M |
December 31, 2021 | 158.21M |
September 30, 2021 | 135.90M |
June 30, 2021 | 124.84M |
Date | Value |
---|---|
March 31, 2021 | 112.85M |
December 31, 2020 | 105.65M |
September 30, 2020 | 103.27M |
June 30, 2020 | 100.50M |
March 31, 2020 | 99.34M |
December 31, 2019 | 91.27M |
September 30, 2019 | 80.13M |
June 30, 2019 | 68.66M |
March 31, 2019 | 58.59M |
December 31, 2018 | 49.45M |
September 30, 2018 | 43.45M |
June 30, 2018 | 38.91M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
91.27M
Minimum
Dec 2019
212.95M
Maximum
Sep 2022
159.42M
Average
177.82M
Median
Mar 2022
SG&A Expense (TTM) Benchmarks
ResMed Inc | 917.14M |
RxSight Inc | 87.92M |
Perspective Therapeutics Inc | 18.64M |
Xtant Medical Holdings Inc | 79.82M |
Catheter Precision Inc | 10.84M |